It is a pleasure to report that the PainChek Limited (ASX:PCK) is up 56% in the last quarter. But that doesn't change the fact that the returns over the last half decade have been stomach churning.

Want to participate in a short research study? Help shape the future of investing tools and receive a $20 prize! Zero-debt allows substantial financial flexibility, especially for small-cap companies ...

Experienced app marketing and growth specialist Sasha Grant appointed head of growth for PainChek Infant App Grant to lead scale-up and rollout of the app, which has regulatory clearance in Australia ...

Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter ...

Australian digital health company PainChek recently announced that the United States Patent Office has issued a Notice of Allowance for its pain assessment invention. This means that patent ...

The PainChek app uses AI to analyse facial muscle movements and detect pain in adults patients with dementia and cognitive impairment. PainChek App uses AI to analyse facial muscle movements and ...